Center-Authored Papers

Filters: Author is Sorror, Mohamed L  [Clear All Filters]
2004
Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C, Maloney DG, Storb R.  2004.  Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.. Blood. 104(4):961-8. Abstract
Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG, Sandmaier BM, Storb R.  2004.  Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.. Blood. 104(5):1550-8. Abstract
2005
Sorror ML, Leisenring W, Deeg HJ, Martin PJ, Storb R.  2005.  Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 11(7):567-8.
Sorror ML, Maris MB, Sandmaier BM, Storer BE, Stuart MJ, Hegenbart U, Agura E, Chauncey TR, Leis J, Pulsipher M et al..  2005.  Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(16):3819-29. Abstract
Parikh CR, Schrier RW, Storer B, Diaconescu R, Sorror ML, Maris MB, Maloney DG, McSweeney P, Storb R, Sandmaier BM.  2005.  Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.. American journal of kidney diseases : the official journal of the National Kidney Foundation. 45(3):502-9. Abstract
Sorror M, Maris M, Diaconescu R, Storb R.  2005.  Lessened severe graft-versus-host after "minitransplantations".. Blood. 105(6):2614.
Baron F, Maris MB, Sandmaier BM, Storer BE, Sorror M, Diaconescu R, Woolfrey AE, Chauncey TR, Flowers MED, Mielcarek M et al..  2005.  Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(9):1993-2003. Abstract
Baron F, Maris MB, Storer BE, Sandmaier BM, Panse JP, Chauncey TR, Sorror M, Little M-T, Maloney DG, Storb R et al..  2005.  High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 19(5):822-8. Abstract
Sorror ML, Leisenring W, Deeg HJ, Martin PJ, Storb R.  2005.  Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 11(10):814-5.
Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B.  2005.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.. Blood. 106(8):2912-9. Abstract
2006
Gopal AK, Pagel JM, Rajendran JG, Maloney DG, Appelbaum FR, Sorror ML, Sandmaier BM, Storb R, Press OW.  2006.  Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 12(7):697-702. Abstract
2007
Georges GE, Maris MB, Maloney DG, Sandmaier BM, Sorror ML, Shizuru JA, Lange T, Agura ED, Bruno B, McSweeney PA et al..  2007.  Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 13(4):423-32. Abstract
Mielcarek M, Storer BE, Sandmaier BM, Sorror ML, Maloney DG, Petersdorf E, Martin PJ, Storb R.  2007.  Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 13(12):1499-507. Abstract
Sorror ML, Giralt S, Sandmaier BM, DeLima M, Shahjahan M, Maloney DG, Deeg HJ, Appelbaum FR, Storer B, Storb R.  2007.  Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.. Blood. 110(13):4606-13. Abstract
Sorror ML, Sandmaier BM, Storer BE, Maris MB, Baron F, Maloney DG, Scott BL, Deeg HJ, Appelbaum FR, Storb R.  2007.  Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(27):4246-54. Abstract
2008
Sorror ML, Leisenring WM, Mielcarek M, Baron F, Diaconescu R, Hogan WJ, Graves SS, Storb R.  2008.  Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation.. Transplantation. 85(7):1023-9. Abstract
Sorror ML, Storer BE, Maloney DG, Sandmaier BM, Martin PJ, Storb R.  2008.  Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.. Blood. 111(1):446-52. Abstract
Rezvani AR, Storer BE, Maris M, Sorror ML, Agura E, Maziarz RT, Wade JC, Chauncey TR, Forman SJ, Lange T et al..  2008.  Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(2):211-7. Abstract
Parikh CR, Yarlagadda SG, Storer BE, Sorror ML, Storb R, Sandmaier BM.  2008.  Impact of acute kidney injury on long-term mortality after nonmyeloablative hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(3):309-15. Abstract
Sala-Torra O, Martin PJ, Storer BE, Traina F, Sorror ML, Storb R, Sandmaier BM, Flowers MED.  2008.  Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens.. Bone marrow transplantation. 41(10):887-93. Abstract
Sorror ML, Storer BE, Sandmaier BM, Maloney DG, Chauncey TR, Langston A, Maziarz RT, Pulsipher M, McSweeney PA, Storb R.  2008.  Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.. Cancer. 112(9):1992-2001. Abstract
Rezvani AR, Norasetthada L, Gooley TA, Sorror ML, Bouvier ME, Sahebi F, Agura E, Chauncey TR, Maziarz RT, Maris M et al..  2008.  Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.. British journal of haematology. 143(3):395-403. Abstract
Sorror ML, Storer BE, Sandmaier BM, Maris M, Shizuru J, Maziarz R, Agura E, Chauncey TR, Pulsipher MA, McSweeney PA et al..  2008.  Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(30):4912-20. Abstract
2009
Rotta M, Storer BE, Sahebi F, Shizuru JA, Bruno B, Lange T, Agura ED, McSweeney PA, Pulsipher MA, Hari P et al..  2009.  Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.. Blood. 113(14):3383-91. Abstract
Sorror M.  2009.  Impacts of pretransplant comorbidities on allogeneic hematopoietic cell transplantation (HCT) outcomes.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(1 Suppl):149-53.